General Market Conditions: Overall market sentiment, economic indicators, and global events can influence all stock prices, including GBT.TO.

Company Performance: GBT's financial results (revenue, profit, growth), pipeline progress, and clinical trial outcomes significantly impact investor confidence and stock value.

Industry Trends: Trends within the biotechnology and pharmaceutical sectors, regulatory changes, and competitor activities can affect GBT.TO's perceived value.

News and Events: Company-specific news releases, such as drug approvals, partnerships, or setbacks, can cause rapid price fluctuations in GBT.TO.

Investor Sentiment: Market sentiment, including speculative trading and analyst ratings, plays a key role in the short-term price movements of GBT.TO.

Interest Rates: Changes in interest rates by central banks can impact investment decisions and influence the attractiveness of GBT.TO relative to other investments.

Regulatory Environment: Changes in government regulations related to drug development, approval processes, and pricing can affect the profitability and outlook for GBT.TO.

Competition: The emergence of competing therapies or companies in the same therapeutic areas can create uncertainty and pressure on GBT.TO's stock price.

Macroeconomic Factors: Economic growth, inflation, and unemployment rates can affect consumer spending and healthcare demand, indirectly impacting GBT.TO.

Currency Exchange Rates: Fluctuations in currency exchange rates, particularly if GBT has international operations or revenue streams, can impact its financial performance.

Supply and Demand: The basic forces of supply and demand in the stock market drive the price of GBT.TO. High demand pushes the price up, while increased supply can lower it.